Riskpilot← Back to searchSign inGet full accessQuijotada AB
ABActiveOrg 5591239941Gamla Lundbygatan 26General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2025
SEK 150K
EBITDA margin
17.7%
+123% vs 2024
Equity ratio
32.3%
Financial strength
Net profit 2025
SEK -123K
-10% vs 2024
| Revenue | SEK 150K | — |
| EBITDA | SEK 27K | +123% |
| Net profit | SEK -123K | -10% |
| Total assets | SEK 57K | -78% |
| Equity | SEK 19K | -87% |
| Employees | 1 | — |
Legal name
Quijotada AB
Org number
5591239941
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 september 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvårdsverksamhet, handel med medicinsk utrustning, ägande och förvaltning av fast egendom och värdepapper samt därmed förenlig verksamhet.
Address
Gamla Lundbygatan 26
Email
jfrones@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 379 | 369 | 150 | 0 | 150 |
| Staff expenses | — | −100 | −130 | −110 | −115 |
| EBITDA | 97 | 226 | −3 | −114 | 27 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 97 | 226 | −3 | −114 | −123 |
| Net financials | — | −2 | −0 | 2 | 0 |
| Profit before tax | 97 | 224 | −3 | −112 | −123 |
| Tax | −21 | −46 | — | — | — |
| Net profit | 76 | 178 | −3 | −112 | −123 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 439 | 487 | 330 | 265 | 57 |
| Equity | 179 | 356 | 254 | 141 | 19 |
| Long-term debt | 117 | 14 | 19 | 101 | 36 |
| Short-term debt | 144 | 116 | 58 | 23 | 3 |
| Total debt | 261 | 130 | 77 | 124 | 39 |
EBITDA margin
17.7%
This company
15.8%
Market median
+12% vs market
20212025
Equity ratio
32.3%
This company
38.2%
Market median
+15% vs market
20212025
Return on equity
-664.3%
This company
18.4%
Market median
-3710% vs market
20212025
Net profit margin
-82.0%
This company
8.1%
Market median
-1112% vs market
20212025
Asset turnover
2.62×
This company
1.12×
Market median
+134% vs market
20212025
Debt / equity
2.10×
This company
0.62×
Market median
-239% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Quijotada AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Andreas Frones | Deputy Board Member | 0 companies |
| Jorge Waldemar Frones Borges | Board of Directors | 0 companies |